Intravitreal steroids in the management of macular oedema.
The use of intravitreal corticosteroids in the management of macular oedema has recently gained widespread acceptance. New long-acting steroid preparations and methods of delivery have facilitated the use of these new modalities. This review describes the various types of macular oedema for which this therapeutic option is used and the results.
Sivaprasad
Sobha
S
Department of Clinical Ophthalmology, Institute of Ophthalmology, Moorfields Eye Hospital, London, UK.
McCluskey
Peter
P
Lightman
Susan
S
D003907:Dexamethasone / Q000627:therapeutic use; D005446:Fluocinolone Acetonide / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007249:Inflammation / Q000150:complications; D007267:Injections; D008269:Macular Edema / Q000188:drug therapy* / Q000209:etiology; D012170:Retinal Vein Occlusion / Q000150:complications; D014222:Triamcinolone Acetonide / Q000627:therapeutic use; D014822:Vitreous Body / Q000187:drug effects
D005938:Glucocorticoids; D005446:Fluocinolone Acetonide; D003907:Dexamethasone; D014222:Triamcinolone Acetonide